risks of glp 1 inhibitors Overdose increase as demand for injectable weight-loss drugs on the rise, research finds Part 2 of a 3-Part

CU Cancer Center member Bryan Haugen, MD, breaks down the science behind the FDA warning on the GLP-1 weight-loss medications.

Although people appear to regain weight rapidly after taking GLP-1 weight-loss drugs this may plateau after time.

list price as of April 2026 (Novo Nordisk published pricing)

Potential neural mechanisms for effects of GLP-1RAs on nicotine reward are reviewed, and priorities for future clinical and translational studies are discussed

Probiotics (50 Billion CFUs) Gut health + digestion support

Semaglutide can lower blood pressure through weight loss and direct cardiovascular effects, but individual responses vary significantly